1/25/2022 | 2933998008 | IRBESARTAN , WORKING STANDARD NON-DRUG, POWDER, REFERENCE SAMPLE, FOR EXAMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, FOR LABORATORS. STUDIES WILL NOT BE USED FOR PREVENTION, DIAGNOSIS, TREATMENT | 0 | 511.12 | France | MOSCOW RUSSIA | CLOSED JSC KANONFARMA PRODUCTION |
1/25/2022 | 2933998008 | IRBESARTAN IMPURITY A , WORKING STANDARD NON-DRUG, POWDER, REFERENCE SAMPLE, FOR EXAMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, FOR LABORATORY. STUDIES WILL NOT BE USED FOR PREVENTION, DIAGNOSIS, | 0 | 2401.12 | France | MOSCOW RUSSIA | CLOSED JSC KANONFARMA PRODUCTION |
1/24/2022 | 3004900002 | MEDICINES FOR RETAIL SALE: APROVEL (IRBESARTAN) FILM-COATED TABLETS 300 MG (BLISTERS) -14 No. 2 -144 UPAK, OKPD2 CODE 21.20.10.148, art. 805224 ADDITION, | 4.61 | 542.19 | France | MOSCOW RUSSIA | SANOFI RUSSIA JSC |
1/14/2022 | 3004900002 | MEDICINES FOR RETAIL SALE: COAPROVEL (IRBESARTAN+HYDROCHLOROTHIAZIDE) TABLETS 150 MG+12.5 MG (BLISTERS) -14 No. 2 -24293 UPAK, ART. 397509, CODE OKPD2 21.20.10.148 GROSS WEIGHT WITH PALLETS 601.37 KG | 485.86 | 75215.6 | France | MOSCOW RUSSIA | SANOFI RUSSIA JSC |
1/24/2022 | 3004900008 | MEDICINES NOT FOR RETAIL IN BULK APROVASC (AMLOLIPIN+IRBESARTAN) FILM-COATED TABLETS 10 MG +300 MG 7#4 .-13940 | 418.2 | 44262.8 | Mexico | MOSCOW RUSSIA | SANOFI RUSSIA JSC |
1/24/2022 | 3004900002 | MEDICINES FOR RETAIL SALE: COAPROVEL (IRBESARTAN+HYDROCHLOROTHIAZIDE) TABLETS 150 MG+12.5 MG (BLISTERS) -14 No. 2 -5184 UPAK, ART. 397509, CODE OKPD2 21.20.10.148 GROSS WEIGHT WITH PALLETS 127.160 KG | 103.68 | 15609.6 | France | MOSCOW RUSSIA | SANOFI RUSSIA JSC |
1/11/2022 | 2933998008 | IRBESARTAN(IRBESARTAN) , PHARMACEUTICAL SUBSTANCE, POWDER. | 20 | 2802.3 | China | MOSCOW RUSSIA | CLOSED JSC KANONFARMA PRODUCTION |